Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 1/2024

27.09.2023 | Originalien

Association between gout and the risk of osteoporosis and fractures: a meta-analysis

verfasst von: Yani Liu, MD, Jihua Feng, MD, Pan Ji, MD, Wei Chen, MD, Ruiqi Yang, MD, Jianfeng Zhang, MD PhD

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

The relationship between gout and osteoporosis is poorly clarified, and the association between gout and fractures incidence remains controversial. Hence, in the present study, we aimed to comprehensively evaluate the available literature to elucidate whether gout is associated with an increased risk of both osteoporosis and fractures.

Materials and methods

We conducted an exhaustive search of pertinent literature published until 20 March 2023, in well-recognized databases, namely Medline, Embase and Cochrane Library, focusing on examining the association between gout and the risk of osteoporosis or fracture. Meta-analysis was performed to aggregate the relative risks (RR) using random- or fixed-effects models. Sensitivity analyses were conducted iteratively, whereby each study was removed sequentially to gauge its impact on the overall outcome. Publication bias was assessed using Egger’s and Begg’s tests. This study was registered with PROSPERO (registry number: CRD42022376822).

Results

Herein, we included 10 observational studies comprising a total of 1,606,095 participants. An independent population sample of four studies validated the significant association between gout and osteoporosis (RR = 1.25, 95% confidence interval [CI] 1.05–1.48), with the results demonstrating robustness. However, our analysis did not detect any association between gout and fracture risk when compared with the control group (RR = 1.09, 95%CI 0.99–1.19), along with high heterogeneity (p for heterogeneity = 0.000; I2 = 79.7%). Further subgroup analysis revealed that gout is positively associated with fracture risk in the Chinese population (RR = 1.17, 95%CI 1.14–1.21), with no evidence of heterogeneity (p for heterogeneity = 0.420; I2 = 0.00%).

Conclusion

Our meticulous evaluation of the available literature indicates that gout has no discernible impact on fracture incidence, although it is positively associated with an enhanced risk of osteoporosis. Therefore, it is imperative to prioritize preventive measures to prevent osteoporotic complications in individuals diagnosed with gout.
Literatur
1.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed
2.
3.
Zurück zum Zitat Chen W, Roncal-Jimenez C, Lanaspa M et al (2014) Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 63:150–160CrossRefPubMed Chen W, Roncal-Jimenez C, Lanaspa M et al (2014) Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 63:150–160CrossRefPubMed
4.
5.
Zurück zum Zitat Dennison EM, Rubin KH, Schwarz P et al (2015) Is allopurinol use associated with an excess risk of osteoporotic fracture? A national prescription registry study. Arch Osteoporos 10:36CrossRefPubMedPubMedCentral Dennison EM, Rubin KH, Schwarz P et al (2015) Is allopurinol use associated with an excess risk of osteoporotic fracture? A national prescription registry study. Arch Osteoporos 10:36CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Dogru A, Balkarli A, Karatay CC et al (2019) Bone mineral density and serum osteocalcin levels in patients with gout. Acta Clin Belg 74:252–257CrossRefPubMed Dogru A, Balkarli A, Karatay CC et al (2019) Bone mineral density and serum osteocalcin levels in patients with gout. Acta Clin Belg 74:252–257CrossRefPubMed
7.
8.
Zurück zum Zitat Ferrández-Jiménez M, Calabuig I, Peral-Garrido ML et al (2022) Risk of osteoporotic thoracic vertebral fractures in patients with gout. Reumatol Clin (Engl Ed) 18:279–285CrossRefPubMed Ferrández-Jiménez M, Calabuig I, Peral-Garrido ML et al (2022) Risk of osteoporotic thoracic vertebral fractures in patients with gout. Reumatol Clin (Engl Ed) 18:279–285CrossRefPubMed
10.
11.
Zurück zum Zitat Kim SC, Paik JM, Liu J et al (2017) Gout and the risk of non-vertebral fracture. J Bone Miner Res 32:230–236CrossRefPubMed Kim SC, Paik JM, Liu J et al (2017) Gout and the risk of non-vertebral fracture. J Bone Miner Res 32:230–236CrossRefPubMed
12.
Zurück zum Zitat Kok VC, Horng JT, Wang MN et al (2018) Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos Int 29:973–985CrossRefPubMed Kok VC, Horng JT, Wang MN et al (2018) Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals. Osteoporos Int 29:973–985CrossRefPubMed
13.
Zurück zum Zitat Kostev K (2018) Association between gout and osteoporosis risk in the United Kingdom. Osteoporos Int 29:1685CrossRefPubMed Kostev K (2018) Association between gout and osteoporosis risk in the United Kingdom. Osteoporos Int 29:1685CrossRefPubMed
14.
Zurück zum Zitat Kwon MJ, Park JY, Kim SG et al (2022) Potential association of osteoporosis and not osteoporotic fractures in patients with gout: a longitudinal follow-up study. Nutrients 15:134CrossRefPubMedPubMedCentral Kwon MJ, Park JY, Kim SG et al (2022) Potential association of osteoporosis and not osteoporotic fractures in patients with gout: a longitudinal follow-up study. Nutrients 15:134CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lee YM, Fujikado N, Manaka H et al (2010) IL‑1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 22:805–816CrossRefPubMed Lee YM, Fujikado N, Manaka H et al (2010) IL‑1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 22:805–816CrossRefPubMed
16.
Zurück zum Zitat Li L, Tian J, Wang R et al (2022) Trends in risk factor control in patients with gout: data from the national health and nutrition examination survey, 2007–2018. Rheumatology 62:158–168CrossRefPubMed Li L, Tian J, Wang R et al (2022) Trends in risk factor control in patients with gout: data from the national health and nutrition examination survey, 2007–2018. Rheumatology 62:158–168CrossRefPubMed
17.
Zurück zum Zitat Lieben L, Carmeliet G (2013) Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis. Bone 54:237–243CrossRefPubMed Lieben L, Carmeliet G (2013) Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis. Bone 54:237–243CrossRefPubMed
19.
20.
Zurück zum Zitat Liu N, Xu H, Sun Q et al (2021) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021:1470380PubMedPubMedCentral Liu N, Xu H, Sun Q et al (2021) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021:1470380PubMedPubMedCentral
21.
Zurück zum Zitat Luo C, Lian X, Hong L et al (2016) High uric acid activates the ROS-AMPK pathway, impairs CD68 expression and inhibits oxLDL-induced foam-cell formation in a human monocytic cell line, THP‑1. Cell Physiol Biochem 40:538–548CrossRefPubMed Luo C, Lian X, Hong L et al (2016) High uric acid activates the ROS-AMPK pathway, impairs CD68 expression and inhibits oxLDL-induced foam-cell formation in a human monocytic cell line, THP‑1. Cell Physiol Biochem 40:538–548CrossRefPubMed
22.
Zurück zum Zitat Paik JM, Kim SC, Feskanich D et al (2017) Gout and risk of fracture in women: a prospective cohort study. Arthritis Rheumatol 69:422–428CrossRefPubMedPubMedCentral Paik JM, Kim SC, Feskanich D et al (2017) Gout and risk of fracture in women: a prospective cohort study. Arthritis Rheumatol 69:422–428CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Preyer O, Concin H, Nagel G et al (2021) Serum uric acid is associated with incident hip fractures in women and men—results from a large Austrian population-based cohort study. Maturitas 148:46–53CrossRefPubMed Preyer O, Concin H, Nagel G et al (2021) Serum uric acid is associated with incident hip fractures in women and men—results from a large Austrian population-based cohort study. Maturitas 148:46–53CrossRefPubMed
24.
Zurück zum Zitat Ramos GK, Goldfarb DS (2022) Update on uric acid and the kidney. Curr Rheumatol Rep 24:132–138CrossRefPubMed Ramos GK, Goldfarb DS (2022) Update on uric acid and the kidney. Curr Rheumatol Rep 24:132–138CrossRefPubMed
25.
Zurück zum Zitat Schröder K (2019) NADPH oxidases in bone homeostasis and osteoporosis. Free Radic Biol Med 132:67–72CrossRefPubMed Schröder K (2019) NADPH oxidases in bone homeostasis and osteoporosis. Free Radic Biol Med 132:67–72CrossRefPubMed
26.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
27.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMed Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMed
28.
Zurück zum Zitat Sultan AA, Whittle R, Muller S et al (2018) Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. CMAJ 190:E581–E587CrossRefPubMedPubMedCentral Sultan AA, Whittle R, Muller S et al (2018) Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. CMAJ 190:E581–E587CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19:60CrossRefPubMed Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19:60CrossRefPubMed
30.
Zurück zum Zitat Tzeng HE, Lin CC, Wang IK et al (2016) Gout increases risk of fracture: a nationwide population-based cohort study. Medicine 95:e4669CrossRefPubMedPubMedCentral Tzeng HE, Lin CC, Wang IK et al (2016) Gout increases risk of fracture: a nationwide population-based cohort study. Medicine 95:e4669CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Wang Y, Zhou R, Zhong W et al (2018) Association of gout with osteoporotic fractures. Int Orthop 42:2041–2047CrossRefPubMed Wang Y, Zhou R, Zhong W et al (2018) Association of gout with osteoporotic fractures. Int Orthop 42:2041–2047CrossRefPubMed
32.
Zurück zum Zitat Yin P, Lv H, Li Y et al (2017) The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis. Osteoporos Int 28:2299–2307CrossRefPubMed Yin P, Lv H, Li Y et al (2017) The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis. Osteoporos Int 28:2299–2307CrossRefPubMed
33.
Zurück zum Zitat Ying W (2008) NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxidants Redox Signal 10:179–206CrossRef Ying W (2008) NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxidants Redox Signal 10:179–206CrossRef
34.
Zurück zum Zitat Zong Q, Hu Y, Zhang Q et al (2019) Associations of hyperuricemia, gout, and UA-lowering therapy with the risk of fractures: a meta-analysis of observational studies. Joint Bone Spine 86:419–427CrossRefPubMed Zong Q, Hu Y, Zhang Q et al (2019) Associations of hyperuricemia, gout, and UA-lowering therapy with the risk of fractures: a meta-analysis of observational studies. Joint Bone Spine 86:419–427CrossRefPubMed
35.
Zurück zum Zitat Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10:207–220CrossRefPubMed Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10:207–220CrossRefPubMed
Metadaten
Titel
Association between gout and the risk of osteoporosis and fractures: a meta-analysis
verfasst von
Yani Liu, MD
Jihua Feng, MD
Pan Ji, MD
Wei Chen, MD
Ruiqi Yang, MD
Jianfeng Zhang, MD PhD
Publikationsdatum
27.09.2023
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-023-01432-4

Weitere Artikel der Sonderheft 1/2024

Zeitschrift für Rheumatologie 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.